Extensive Longitudinal Transverse Myelitis Temporally Related to the Use of AZD1222, AstraZeneca COVID-19 Vaccine: Cerebrospinal Fluid Analysis and Recent Data Review
While mass immunization against coronavirus disease 2019 (COVID-19) rolls out around the globe, safety concerns and adverse events that need prompt evaluation are also emerging. Neurological complications such as transverse myelitis raise concerns as cases were observed in clinical trials. Cerebrosp...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Neurological Medicine |
Online Access: | http://dx.doi.org/10.1155/2022/8999853 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832565515752570880 |
---|---|
author | Paulo Diniz da Gama Tiago Gomes de Alcantara Rafaela Ramos Smaniotto Penélope de Lima Petuco Wammer Alves de Almeida Rodrigo Assad Diiniz da Gama Yara Dadalti Fragoso |
author_facet | Paulo Diniz da Gama Tiago Gomes de Alcantara Rafaela Ramos Smaniotto Penélope de Lima Petuco Wammer Alves de Almeida Rodrigo Assad Diiniz da Gama Yara Dadalti Fragoso |
author_sort | Paulo Diniz da Gama |
collection | DOAJ |
description | While mass immunization against coronavirus disease 2019 (COVID-19) rolls out around the globe, safety concerns and adverse events that need prompt evaluation are also emerging. Neurological complications such as transverse myelitis raise concerns as cases were observed in clinical trials. Cerebrospinal fluid analysis is routine in these cases and the characteristics of the abnormalities found are of great help not only in establishing the diagnosis but also in understanding this rare condition. We present a case of extensive longitudinal transverse myelitis after vaccination with AZD1222, AstraZeneca COVID-19 vaccine, which was the first case reported in Brazil. The abnormalities found in the study of the cerebrospinal fluid in our case are reported and discussed using data from recent publications. |
format | Article |
id | doaj-art-769d223e7e544d379d7037487b2a4776 |
institution | Kabale University |
issn | 2090-6676 |
language | English |
publishDate | 2022-01-01 |
publisher | Wiley |
record_format | Article |
series | Case Reports in Neurological Medicine |
spelling | doaj-art-769d223e7e544d379d7037487b2a47762025-02-03T01:07:22ZengWileyCase Reports in Neurological Medicine2090-66762022-01-01202210.1155/2022/8999853Extensive Longitudinal Transverse Myelitis Temporally Related to the Use of AZD1222, AstraZeneca COVID-19 Vaccine: Cerebrospinal Fluid Analysis and Recent Data ReviewPaulo Diniz da Gama0Tiago Gomes de Alcantara1Rafaela Ramos Smaniotto2Penélope de Lima Petuco3Wammer Alves de Almeida4Rodrigo Assad Diiniz da Gama5Yara Dadalti Fragoso6Faculty of Medical Sciences of SorocabaThe Conjunto Hospitalar de SorocabaFaculty of Medical Sciences of SorocabaFaculty of Medical Sciences of SorocabaFaculty of Medical Sciences of SorocabaThe Conjunto Hospitalar de SorocabaUniversidade Metropolitana de SantosWhile mass immunization against coronavirus disease 2019 (COVID-19) rolls out around the globe, safety concerns and adverse events that need prompt evaluation are also emerging. Neurological complications such as transverse myelitis raise concerns as cases were observed in clinical trials. Cerebrospinal fluid analysis is routine in these cases and the characteristics of the abnormalities found are of great help not only in establishing the diagnosis but also in understanding this rare condition. We present a case of extensive longitudinal transverse myelitis after vaccination with AZD1222, AstraZeneca COVID-19 vaccine, which was the first case reported in Brazil. The abnormalities found in the study of the cerebrospinal fluid in our case are reported and discussed using data from recent publications.http://dx.doi.org/10.1155/2022/8999853 |
spellingShingle | Paulo Diniz da Gama Tiago Gomes de Alcantara Rafaela Ramos Smaniotto Penélope de Lima Petuco Wammer Alves de Almeida Rodrigo Assad Diiniz da Gama Yara Dadalti Fragoso Extensive Longitudinal Transverse Myelitis Temporally Related to the Use of AZD1222, AstraZeneca COVID-19 Vaccine: Cerebrospinal Fluid Analysis and Recent Data Review Case Reports in Neurological Medicine |
title | Extensive Longitudinal Transverse Myelitis Temporally Related to the Use of AZD1222, AstraZeneca COVID-19 Vaccine: Cerebrospinal Fluid Analysis and Recent Data Review |
title_full | Extensive Longitudinal Transverse Myelitis Temporally Related to the Use of AZD1222, AstraZeneca COVID-19 Vaccine: Cerebrospinal Fluid Analysis and Recent Data Review |
title_fullStr | Extensive Longitudinal Transverse Myelitis Temporally Related to the Use of AZD1222, AstraZeneca COVID-19 Vaccine: Cerebrospinal Fluid Analysis and Recent Data Review |
title_full_unstemmed | Extensive Longitudinal Transverse Myelitis Temporally Related to the Use of AZD1222, AstraZeneca COVID-19 Vaccine: Cerebrospinal Fluid Analysis and Recent Data Review |
title_short | Extensive Longitudinal Transverse Myelitis Temporally Related to the Use of AZD1222, AstraZeneca COVID-19 Vaccine: Cerebrospinal Fluid Analysis and Recent Data Review |
title_sort | extensive longitudinal transverse myelitis temporally related to the use of azd1222 astrazeneca covid 19 vaccine cerebrospinal fluid analysis and recent data review |
url | http://dx.doi.org/10.1155/2022/8999853 |
work_keys_str_mv | AT paulodinizdagama extensivelongitudinaltransversemyelitistemporallyrelatedtotheuseofazd1222astrazenecacovid19vaccinecerebrospinalfluidanalysisandrecentdatareview AT tiagogomesdealcantara extensivelongitudinaltransversemyelitistemporallyrelatedtotheuseofazd1222astrazenecacovid19vaccinecerebrospinalfluidanalysisandrecentdatareview AT rafaelaramossmaniotto extensivelongitudinaltransversemyelitistemporallyrelatedtotheuseofazd1222astrazenecacovid19vaccinecerebrospinalfluidanalysisandrecentdatareview AT penelopedelimapetuco extensivelongitudinaltransversemyelitistemporallyrelatedtotheuseofazd1222astrazenecacovid19vaccinecerebrospinalfluidanalysisandrecentdatareview AT wammeralvesdealmeida extensivelongitudinaltransversemyelitistemporallyrelatedtotheuseofazd1222astrazenecacovid19vaccinecerebrospinalfluidanalysisandrecentdatareview AT rodrigoassaddiinizdagama extensivelongitudinaltransversemyelitistemporallyrelatedtotheuseofazd1222astrazenecacovid19vaccinecerebrospinalfluidanalysisandrecentdatareview AT yaradadaltifragoso extensivelongitudinaltransversemyelitistemporallyrelatedtotheuseofazd1222astrazenecacovid19vaccinecerebrospinalfluidanalysisandrecentdatareview |